<DOC>
	<DOCNO>NCT00319111</DOCNO>
	<brief_summary>The present trial investigate long-term safety , tolerability efficacy bosentan patient inoperable CTEPH .</brief_summary>
	<brief_title>Bosentan Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension ( CTEPH )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Bosentan</mesh_term>
	<criteria>Patients complete 16week treatment period protocol AC052366 ( NCT00313222 ) Signed informed consent Any major violation protocol AC052366 ( NCT00313222 ) Pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>pulmonary hypertension</keyword>
	<keyword>bosentan</keyword>
	<keyword>BENEFIT</keyword>
	<keyword>CTEPH</keyword>
	<keyword>inoperable chronic thromboembolic pulmonary hypertension ( CTEPH )</keyword>
</DOC>